Folgen
Aleksander Krag
Aleksander Krag
Professor of Hepatology, Odense Universityhospital
Bestätigte E-Mail-Adresse bei rsyd.dk
Titel
Zitiert von
Zitiert von
Jahr
Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension
BVIF de Franchis, Roberto
Journal of Hepatology 63 (3), 743-52, 2015
39742015
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
P Angeli, M Bernardi, C Villanueva, C Francoz, RP Mookerjee, J Trebicka, ...
Journal of hepatology 69 (2), 406-460, 2018
25692018
Baveno VII–renewing consensus in portal hypertension
R De Franchis, J Bosch, G Garcia-Tsao, T Reiberger, C Ripoll, ...
Journal of hepatology 76 (4), 959-974, 2022
18972022
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
11652019
Liver cirrhosis
P Ginès, A Krag, JG Abraldes, E Solà, N Fabrellas, PS Kamath
The Lancet 398 (10308), 1359-1376, 2021
10482021
Spontaneous bacterial peritonitis: recent guidelines and beyond
R Wiest, A Krag, A Gerbes
Gut 61 (2), 297-310, 2012
5212012
Assessment of biopsy‐proven liver fibrosis by two‐dimensional shear wave elastography: An individual patient data‐based meta‐analysis
E Herrmann, V de Lédinghen, C Cassinotto, WCW Chu, VYF Leung, ...
Hepatology 67 (1), 260-272, 2018
4802018
Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites
A Krag, F Bendtsen, JH Henriksen, S Møller
Gut 59 (01), 105-110, 2010
4742010
Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide
S Piano, V Singh, P Caraceni, R Maiwall, C Alessandria, J Fernandez, ...
Gastroenterology 156 (5), 1368-1380. e10, 2019
4442019
Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome
LL Gluud, K Christensen, E Christensen, A Krag
Hepatology 51 (2), 576-584, 2010
4192010
The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease
A Krag, R Wiest, A Albillos, LL Gluud
Gut 61 (7), 967-969, 2012
2712012
Novel insights into the function and dynamics of extracellular matrix in liver fibrosis
MA Karsdal, T Manon-Jensen, F Genovese, JH Kristensen, MJ Nielsen, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 308 (10 …, 2015
2572015
Banding ligation versus beta‐blockers for primary prevention in oesophageal varices in adults
LL Gluud, A Krag
Cochrane Database of Systematic Reviews, 2012
2542012
Transient and 2-dimensional shear-wave elastography provide comparable assessment of alcoholic liver fibrosis and cirrhosis
M Thiele, S Detlefsen, LS Møller, BS Madsen, JF Hansen, AD Fialla, ...
Gastroenterology 150 (1), 123-133, 2016
2502016
Terlipressin for hepatorenal syndrome
LL Gluud, K Christensen, E Christensen, A Krag
Cochrane Database of Systematic Reviews, 2012
2502012
Accuracy of the enhanced liver fibrosis test vs FibroTest, elastography, and indirect markers in detection of advanced fibrosis in patients with alcoholic liver disease
M Thiele, BS Madsen, JF Hansen, S Detlefsen, S Antonsen, A Krag
Gastroenterology 154 (5), 1369-1379, 2018
2452018
Systematic review with meta‐analysis: the effects of rifaximin in hepatic encephalopathy
N Kimer, A Krag, S Møller, F Bendtsen, LL Gluud
Alimentary pharmacology & therapeutics 40 (2), 123-132, 2014
2322014
ADAPT: an algorithm incorporating PRO‐C3 accurately identifies patients with NAFLD and advanced fibrosis
SJ Daniels, DJ Leeming, M Eslam, AM Hashem, MJ Nielsen, A Krag, ...
Hepatology 69 (3), 1075-1086, 2019
2292019
Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis
M Simón-Talero, D Roccarina, J Martínez, K Lampichler, A Baiges, G Low, ...
Gastroenterology 154 (6), 1694-1705. e4, 2018
2292018
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis
D Petroff, V Blank, PN Newsome, CS Voican, M Thiele, V de Lédinghen, ...
The Lancet Gastroenterology & Hepatology 6 (3), 185-198, 2021
2042021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20